Create a free research account to view current pricing and place an order.
How does Kisspeptin work in research models?
Kisspeptin activates KISS1 receptors upstream of hypothalamic GnRH signaling, influencing LH/FSH pulsatility and reproductive-axis regulation.
What is the half-life of Kisspeptin?
Half-life: Short acting.
Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise.
Research dosing reference
100-500 mcg daily or pulse-style reproductive-axis research exposure.
Dose interpretation (U-100 units)
| Target dose | U-100 units |
|---|---|
| 100 mcg | 2 units |
| 250 mcg | 5 units |
| 500 mcg | 10 units |
Units are concentration-specific - confirm against your actual reconstitution volume.
How is Kisspeptin reconstituted?
| Vial | Preferred reconstitution | Final concentration |
|---|---|---|
| 10 mg | 2 mL BAC Water | 0.050 mg/unit |
Injection timing
Often timed based on reproductive-axis objective; consistency and pulse logic matter.
Beginner escalation
Begin low and assess endocrine response before increasing frequency or dose.
Side-effect mitigation
Monitor mood, libido changes, flushing, headache, or endocrine-axis symptoms.
Stack compatibility
Avoid stacking with multiple HPG-axis agents without lab interpretation.
Storage & stability
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically.
Protocol duration & reassessment
Use objective-driven, marker-aware courses. Reassess endocrine, mood, libido, blood-pressure, or target-symptom response before repeating or escalating.
Frequently asked questions
What is Kisspeptin and how is it studied?
Kisspeptin activates KISS1 receptors upstream of hypothalamic GnRH signaling, influencing LH/FSH pulsatility and reproductive-axis regulation. Kisspeptin is catalogued in the Hormonal / Miscellaneous group of this reference and is studied in laboratory and in-vitro models only. Kisspeptin is listed in this reference for laboratory context only; nothing here describes use in a person or animal.
What is known about the half-life of Kisspeptin?
Reference half-life for Kisspeptin: short acting. Human pharmacokinetics are not standardized. Treat exposure as short acting unless compound-specific data or formal formulation labeling indicates otherwise. Published pharmacokinetic figures come from research and clinical-literature contexts and are listed here as reference values for laboratory work only, not as guidance for any person or animal.
How is Kisspeptin stored?
Lyophilized: refrigerated or controlled cool storage. Reconstituted: refrigerated, protected from heat/light, and handled aseptically. Lyophilized research peptides are generally kept cold, dry, and away from light, and reconstituted solutions are labeled with concentration and date. Follow the storage conditions documented for the specific lot you receive.
How is Kisspeptin reconstituted for laboratory work?
The reference reconstitution for the 10 mg vial is 2 mL BAC Water, which gives a concentration of about 5 mg/mL. Concentration equals peptide mass divided by diluent volume, so adding more liquid lowers the concentration. Add diluent slowly down the vial wall, swirl rather than shake, and confirm the arithmetic before preparing any research solution.
Is Kisspeptin FDA approved?
No. The research-grade Kisspeptin described here is an investigational, research-use-only material and is not an FDA-approved drug product. Where an approved pharmaceutical form of a compound exists, it is a separate prescription product. This reference is not medical advice, and the material is not for human or animal consumption.
Kisspeptin product overview · Kisspeptin cost · All research reference · Research guides
External references: Peptide (Wikipedia) · U.S. Food and Drug Administration